Stockscreener 앱 받기
1.34
4.96%
-0.07
전일 마감가:
$1.41
열려 있는:
$1.41
하루 거래량:
24,198
Relative Volume:
0.06
시가총액:
$10.71M
수익:
$2.90M
순이익/손실:
$87.91M
주가수익비율:
0.0858
EPS:
15.6103
순현금흐름:
$-26.93M
1주 성능:
+0.75%
1개월 성능:
-44.86%
6개월 성능:
-13.55%
1년 성능:
-83.40%
1일 변동 폭
$1.34
$1.4403
1주일 범위
$1.26
$1.4403
52주 변동 폭
$0.97
$9.31
Traws Pharma Inc Stock (TRAW) Company Profile
명칭
Traws Pharma Inc
전화
267-759-3680
주소
12 PENNS TRAIL, NEWTOWN
TRAW을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TRAW
Traws Pharma Inc
|
1.34 | 11.27M | 2.90M | 87.91M | -26.93M | 15.61 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.86 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
796.55 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
398.29 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
788.49 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.97 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Traws Pharma Inc Stock (TRAW) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-03 | 개시 | H.C. Wainwright | Buy |
| 2022-03-01 | 개시 | Ladenburg Thalmann | Buy |
| 2021-05-18 | 개시 | Guggenheim | Buy |
| 2018-03-01 | 재확인 | H.C. Wainwright | Buy |
| 2018-01-17 | 다운그레이드 | Maxim Group | Buy → Hold |
| 2017-10-09 | 개시 | H.C. Wainwright | Buy |
| 2017-04-27 | 개시 | Laidlaw | Buy |
| 2015-07-01 | 업그레이드 | Piper Jaffray | Neutral → Overweight |
| 2015-05-05 | 개시 | H.C. Wainwright | Buy |
모두보기
Traws Pharma Inc 주식(TRAW)의 최신 뉴스
Published on: 2026-01-11 07:18:09 - ulpravda.ru
Fed Meeting: Is Traws Pharma Inc. stock a buy before product launches2025 Market WrapUp & Weekly Market Pulse Updates - ulpravda.ru
How resilient is Traws Pharma Inc. stock in market downturnsTrade Exit Report & Short-Term Trading Alerts - ulpravda.ru
Why Traws Pharma Inc. stock remains on watchlists2025 Market Outlook & Consistent Profit Trade Alerts - ulpravda.ru
Is Traws Pharma Inc. stock cheap at current valuationMarket Activity Report & Community Trade Idea Sharing - ulpravda.ru
How Traws Pharma Inc. stock compares to industry benchmarksPortfolio Risk Report & High Accuracy Trade Signal Alerts - ulpravda.ru
Comparing Miravant Medical Technologies (OTCMKTS:MRVT) and Traws Pharma (NASDAQ:TRAW) - Defense World
Traws Pharma Pushes Ahead on COVID and Flu Antivirals as Costs Fall and Pipeline Advances - MSN
Traws Pharma, Inc. Appoints Luba Greenwood to Board of Directors - Moscow-Pullman Daily News
Traws Pharma (NASDAQ:TRAW) Shares Down 3.5% – Time to Sell? - Defense World
How Traws Pharma Inc. stock compares to growth peersTechnical Resistance Breaks & Fast Growing Capital Gains - bollywoodhelpline.com
CLARKE TRAFFORD Insider Trades - Nasdaq
Why Traws Pharma Inc. (0T20) stock stays on top picksAnalyst Upgrades & Master Stock Selection - Bollywood Helpline
New COVID Pill Shows Promise Against Paxlovid in Early Head-to-Head Trial - MyChesCo
Life sciences leader behind a $900M pharma sale joins cancer firm - Stock Titan
Is Traws Pharma Inc a good long term investmentRetail Trading Trends & High Return Wealth Building - earlytimes.in
Momentum Shift: Will Traws Pharma Inc. (0T20) stock benefit from mergersMarket Sentiment Report & Real-Time Buy Zone Alerts - Улправда
Traws Pharma Begins Phase 2 Trial of Ritonavir-Free COVID-19 Treatment Ratutrelvir - MSN
How Traws Pharma Inc. stock performs during Fed tightening cyclesJuly 2025 Trade Ideas & Step-by-Step Swing Trade Plans - Улправда
How Traws Pharma Inc. stock reacts to global recession fears2025 Growth vs Value & AI Driven Stock Reports - Улправда
Why Traws Pharma Inc. (0T20) stock stays on buy lists2025 Biggest Moves & Consistent Profit Trading Strategies - DonanımHaber
Aug Momentum: How Traws Pharma Inc. stock reacts to global recession fearsWeekly Investment Recap & Free Technical Confirmation Trade Alerts - Улправда
Will Traws Pharma Inc. (0T20) stock profit from fiscal stimulusJuly 2025 Highlights & Real-Time Volume Surge Alerts - Улправда
Traws Pharma's Oral COVID Drug Shows Comparable Results To Paxlovid - Benzinga
Traws Pharma, Inc. Announces Positive Interim Data for Ratutrelvir in COVID-19 Study - TradingView — Track All Markets
Traws Pharma Reports Promising Interim Data for Ratutrelvir, Showing Favorable Profile Compared to PAXLOVID™ in COVID-19 Treatment - Quiver Quantitative
Traws Pharma (NASDAQ: TRAW) highlights positive Phase 2 COVID data results - Stock Titan
Traws Pharma Reports Positive Interim Clinical Data - One News Page
Ratutrelvir shows promising interim results in COVID-19 trial - Investing.com
Traws Pharma (TRAW) reports director RSU and stock option awards - Stock Titan
[Form 4] Traws Pharma, Inc. Insider Trading Activity - Stock Titan
Traws Pharma, Inc. (TRAW) director awarded RSUs and stock options in 2025 grant - Stock Titan
Traws Pharma (TRAW) director reports equity awards details in Form 4 filing - Stock Titan
Traws Pharma (NASDAQ: TRAW) CEO reports new RSU and stock option awards - Stock Titan
Traws Pharma (TRAW) CSO receives new RSUs and stock options grant - Stock Titan
Traws Pharma (NASDAQ: TRAW) discloses CMO equity grants of stock and options - Stock Titan
Traws Pharma (TRAW) insider granted RSUs and options on 12/12/2025 as equity awards - Stock Titan
Traws Pharma (Nasdaq: TRAW) approves stock option and RSU grants for top executives - Stock Titan
Traws Pharma Earnings Notes - Trefis
Published on: 2025-12-12 06:22:07 - moha.gov.vn
Traws Pharma (TRAW) – Analysts’ Recent Ratings Changes - Defense World
Traws Pharma (NASDAQ:TRAW) Upgraded at Zacks Research - Defense World
0T20 Forecast — Price Target — Prediction for 2026 - TradingView
Traws Pharma (NASDAQ:TRAW) Cut to “Sell” at Wall Street Zen - Defense World
HC Wainwright Estimates Traws Pharma Q4 Earnings - Defense World
Can Traws Pharma Inc. (0T20) stock sustain institutional flowsTrade Risk Assessment & Consistent Growth Equity Picks - Newser
What earnings margins imply for Traws Pharma Inc. (0T20) stock2025 Pullback Review & Scalable Portfolio Growth Methods - Newser
HC Wainwright Begins Coverage on Traws Pharma (NASDAQ:TRAW) - Defense World
Is Traws Pharma Inc. stock trading near support levelsTrade Performance Summary & AI Powered Buy/Sell Recommendations - newser.com
How Traws Pharma Inc. (0T20) stock behaves under inflation pressureJuly 2025 Outlook & Precise Trade Entry Recommendations - Newser
Will Traws Pharma Inc. (0T20) stock benefit from sector leadership2025 Pullback Review & AI Forecasted Entry/Exit Points - Newser
Traws Pharma Inc (TRAW) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.90%
자본화:
|
볼륨(24시간):